Synergy Chc CORP Form 4 insider transactions

Alfred Baumeler, Director and President of Synergy CHC Corp., reports on stock option grants and modifications.

Jaime Fickett, Chief Financial Officer of Synergy CHC Corp., reported a modification to stock options, adjusting exercise prices and vesting schedules.

Synergy CHC Corp. CEO and Chairman Jack Ross reports on stock option transactions, including a modification to an existing option grant.

Director Nitin Kaushal acquired 306,433 restricted stock units in Synergy CHC Corp. which vested immediately upon grant.

Director Teresa Brigid Thompson acquired 25,824 restricted stock units in Synergy CHC Corp. as part of the company's 2024 Equity Incentive Plan.

Synergy CHC Corp. granted 150,000 stock options to President and Director Alfred Baumeler with an exercise price of $2.38.

Synergy CHC Corp.'s Chief Financial Officer, Jaime Fickett, was granted 150,000 stock options with an exercise price of $2.38.

Synergy CHC Corp. CEO and Chairman Jack Ross received a grant of 750,000 stock options with an exercise price of $2.38, vesting over a three-year period.

Synergy CHC Corp.'s CEO and Chairman, Jack Ross, increased his direct beneficial ownership by purchasing 30,000 shares of common stock through multiple open market transactions in June and July 2025.

Knight Therapeutics Inc., through its wholly-owned subsidiary, has acquired 428,570 pre-funded common stock purchase warrants in Synergy CHC Corp., becoming a 10% owner.

Synergy CHC Corp.'s CEO and Chairman, Jack Ross, has increased his direct beneficial ownership in the company by purchasing 16,100 shares of common stock in early June 2025.

CEO Jack Ross reports continued purchases of Synergy CHC Corp. common stock between April 11, 2025, and May 15, 2025, increasing his direct and indirect holdings.

CEO Jack Ross has been consistently purchasing Synergy CHC Corp. stock between February 21, 2025, and April 10, 2025, increasing his holdings.

Synergy CHC Corp.'s CEO and Chairman, Jack Ross, reports continued acquisition of company stock through a series of transactions from January 23, 2025, to February 21, 2025, increasing his direct and indirect holdings.

CEO and Chairman Jack Ross has been consistently purchasing Synergy CHC Corp. (SNYR) stock between November 2024 and January 2025, increasing his holdings.

CEO Jack Ross reports the acquisition of 300,000 shares of Synergy CHC Corp. common stock at $9 per share on October 24, 2024.